Skip to main content
. 2021 Dec 7;28(1):e100458. doi: 10.1136/bmjhci-2021-100458

Table 2.

Renal characteristics, resource utilisation and hospital outcomes during entire hospitalisation by trajectories of AKI in all cohort

Variables All subjects
(N=355 678)
AKI
(N=54 212, 15%)
Persistent AKI without renal recovery (N=14 122, 4%) Persistent AKI with renal recovery (N=8590, 2%) Rapidly reversed AKI (N=31 500, 9%) No AKI
(N=301 466, 85%)
Renal characteristics during entire hospitalisation
Worst AKI staging, n (%)
 Stage 1 36 258 (10) 36 258 (67)* 5210 (37)*†‡ 4176 (49)*† 26 872 (85)* 0 (0)
 Stage 2 9551 (3) 9551 (18)* 3762 (27)*†‡ 2492 (29)*† 3297 (10)* 0 (0)
 Stage 3 8403 (2) 8403 (16)* 5150 (36)*†‡ 1922 (22)*† 1331 (4)* 0 (0)
  Stage three without RRT 6351 (2) 6351 (12)* 3384 (24)*†‡ 1646 (19)*† 1321 (4)* 0 (0)
  Stage three with RRT 2052 (1) 2052 (4)* 1766 (13)*†‡ 276 (3)† 10 (0)* 0 (0)
 AKI duration, days, median (IQR) 2 (1–4) 2 (1–4) 5 (3–9) b‡ 4 (3–7) 1 (1–2) NA
 Recurrent AKI, n (%) 6466 (2) 6466 (12)* 2173 (15)*†‡ 1957 (23)*† 2336 (7)* 0 (0)
 No renal recovery at discharge/death, n (%) 22 240 (6) 22 240 (41)* 14 122 (100)*†‡ 0 (0)† 8118 (26)* 0 (0)
Resource utilisation during entire hospitalisation
 Hospital days, median (IQR) 3 (1–6) 7 (4–14)* 8 (4–15)*†‡ 14 (8–24)*† 6 (3–10)* 2 (1–5)
 Admission to ICU, n (%) 78 769 (22) 27 711 (51)* 8573 (61)*†‡ 5860 (68)*† 13 278 (42)* 51 058 (17)
  Days in ICU, median (IQR) 4 (2–7) 6 (3–12)* 6 (3–13)*†‡ 9 (5–18)*† 5 (3–9)* 3 (–5)
 Mechanical ventilation, n (%) 23 286 (7) 11 876 (22)* 4779 (34)*† 2876 (33)*† 4221 (13)* 11 410 (4)
  Mechanical ventilation calendar days, median (IQR) 3 (2–6) 4 (2–9)* 4 (2–9)*†‡ 5 (2–12)*† 3 (2–7)* 2 (1–4)
 Vasopressor or inotropes used, n (%) 55 415 (16) 17 261 (32)* 6016 (43)*† 3781 (44)*† 7464 (24)* 38 154 (13)
Hospital disposition, n (%)
 Hospital mortality 7799 (2) 4974 (9)* 3918 (28)*†‡ 376 (4)*† 680 (2)* 2825 (1)
 Another hospital, LTAC, SNF, Hospice 34 092 (10) 10 028 (18)* 3011 (21)*†‡ 2494 (29)*† 4523 (14)* 24 064 (8)
 Home/rehab 313 787 (88) 39 210 (72)* 7193 (51)*†‡ 5720 (67)*† 26 297 (83)* 274 577 (91)
 30-day outcomes (among survivors), n (%) 347 879 49 238 (14) 10 204 (3) 8214 (2) 30 820 (9) 298 641 (86)
 Death in 30 days of discharge 4934 (1) 1776 (4)* 570 (6)*† 418 (5)*† 788 (3)* 3158 (1)
 Trajectory group for encounter with readmission within 30 days of discharge 83 592 (24) 12 748 (26)* 2528 (25)‡ 2381 (29)*† 7839 (25)* 70 844 (24)
  Persistent AKI with no renal recovery 2764 (3) 1297 (10)* 536 (21)*†‡ 223 (9)*† 538 (7)* 1467 (2)
  Persistent AKI with renal recovery 2118 (3) 933 (7)* 231 (9)*† 239 (10)*† 463 (6)* 1185 (2)
  Rapidly reversed AKI 7505 (9) 2504 (20)* 502 (20)* 448 (19)* 1554 (20)* 5001 (7)
  No AKI 59 164 (71) 7096 (56)* 1100 (44)*†‡ 1337 (56)*† 4659 (59)* 52 068 (73)
  Unknown 12 041 (14) 918 (7) 159 (6)*† 134 (6)*† 625 (8)* 11 123 (16)
Other complications during entire hospitalisation
 Venous thromboembolism, n (%) 15 755 (4) 5180 (10)* 1589 (11)*†‡ 1290 (15)*† 2301 (7)* 10 575 (4)
 Sepsis, n (%) 29 836 (8) 13 995 (26)* 5102 (36)*†‡ 3275 (38)*† 5618 (18)* 15 841 (5)
 Cardiovascular complication, n (%) 31 780 (9) 15 229 (28)* 5553 (39)*† 3469 (40)*† 6207 (20)* 16 551 (5)
 Thirty-day mortality, n (%) 11 082 (3) 5655 (10)* 3962 (28)*†‡ 506 (6)*† 1187 (4)* 5427 (2)
 One-year mortality, n (%) 34 687 (10) 12 570 (23)* 5802 (41)*†‡ 2054 (24)*† 4714 (15)* 22 117 (7)
 Three-year mortality, n (%) 49 144 (14) 15 703 (29)* 6414 (45)*†‡ 2669 (31)*† 6620 (21)* 33 441 (11)

*P<0.05 compared with rapidly no AKI.

†P<0.05 compared with rapidly reversed AKI.

‡P<0.05 compared with persistent AKI with renal recovery.

AKI, acute kidney injury; ICU, intensive care unit; LTAC, long-term acute care hospital; NA, not applicable; RRT, renal replacement therapy; SNF, skilled nursing facility.